Copyright
©The Author(s) 2025.
World J Hepatol. Jan 27, 2025; 17(1): 101704
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.101704
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.101704
Biochemical parameters | Baseline | 12 weeks | 24 weeks | P value |
Leukocytes in thousands/μL1 | 7.1 (5.3-13.7) | 5.7 (4.5-10) | 7.0 (4.7-12) | 0.876 |
Hb in g/dL2 | 13.4 + 1.3 | 13.1 + 1.3 | 13.3 + 1.2 | 0.101 |
Platelets in miles/μL2 | 278 + 52 | 259 + 59 | 256 + 57 | 0.014 |
TB in mg/dL2 | 0.54 + 0.24 | 0.60 + 0.18 | 0.72 + 0.20 | 0.002 |
AST in U/L1 | 27 (11-49) | 25 (20-63) | 24 (15-45) | 0.201 |
ALT in U/L1 | 32 (4-102) | 30 (17-81) | 25 (17-69) | 0.267 |
ALP in IU/L2 | 99 + 49 | 92 + 24 | 81 + 16 | 0.205 |
GGT in U/L1 | 51 (18-370) | 25 (10-130) | 28 (12-142) | 0.033 |
TP in g/dL1 | 7.4 (6.4-8.3) | 7.4 (6.6-8.1) | 7.4 (7.0-8.3) | 0.125 |
Albumin in g/dL2 | 4.3 + 0.56 | 4.3 + 0.28 | 4.4 + 0.3 | 0.443 |
Cholesterol in mg/dL2 | 202 + 45 | 191 + 52 | 184 + 49 | 0.073 |
HDL in mg/dL1 | 44 (23-66) | 40 (31-61) | 46 (29-168) | 0.850 |
LDL in mg/dL2 | 123 + 41 | 113 + 39 | 110 + 37 | 0.056 |
VLDL in mg/dL2 | 31 + 11 | 41 + 43 | 32 + 15 | 0.663 |
Triglycerides in mg/dL2 | 165 + 11 | 163 + 55 | 32 + 76 | 0.987 |
Glucose in mg/dL1 | 110 (69-316) | 101 (83-200) | 115 (91-242) | 0.616 |
Creatinine in mg/dL2 | 0.77 + 0.16 | 0.67 + 0.14 | 0.66 + 0.25 | 0.223 |
CRP in mg/L1 | 4.60 (0.50-1.03) | 3.90 (1.80-6.00) | 0.51 (0.03-1.40) | 0.035 |
Insulin in mg/L2 | 16.0 + 9.8 | 20.0 + 11.0 | 16.0 + 5.0 | 0.580 |
HOMA2 | 4.8 + 3.0 | 5.7 + 3.3 | 5.3 + 2.8 | 0.230 |
- Citation: Cano Contreras AD, Del Rocío Francisco M, Vargas Basurto JL, Gonzalez-Gomez KD, Amieva-Balmori M, Roesch Dietlen F, Remes-Troche JM. Effect of alpha-lipoic acid and Silybum marianum supplementation with a Mediterranean diet on metabolic dysfunction-associated steatosis. World J Hepatol 2025; 17(1): 101704
- URL: https://www.wjgnet.com/1948-5182/full/v17/i1/101704.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i1.101704